Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy.

about

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy.

Item

http://www.wikidata.org/entity/Q55451529

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Real-world outcomes in patient ...... g mono bronchodilator therapy.

@en

Real-world outcomes in patient ...... g mono bronchodilator therapy.

@nl

type

Item

label

Real-world outcomes in patient ...... g mono bronchodilator therapy.

@en

Real-world outcomes in patient ...... g mono bronchodilator therapy.

@nl

prefLabel

Real-world outcomes in patient ...... g mono bronchodilator therapy.

@en

Real-world outcomes in patient ...... g mono bronchodilator therapy.

@nl

P1476

Real-world outcomes in patient ...... ng mono bronchodilator therapy

@en

P2093

Jeffrey McPheeters

http://www.w3.org/2001/XMLSchema#string

Kathleen M Fox

http://www.w3.org/2001/XMLSchema#string

Michael DePietro

http://www.w3.org/2001/XMLSchema#string

P2860

New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives

Rising Costs of COPD and the Potential for Maintenance Therapy to Slow the Trend

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Deaths: preliminary data for 2011.

An observation of prescription behaviors and adherence to guidelines in patients with COPD: real world data from October 2012 to September 2014.

Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.

Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.

Characteristics of patients with COPD newly prescribed a long-acting bronchodilator: a retrospective cohort study.

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial.

P304

1753466618772750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1753466618772750

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lindsay G S Bengtson

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29737943

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5961922

http://www.w3.org/2001/XMLSchema#string